234 related articles for article (PubMed ID: 27624777)
21. CircNEIL3 regulatory loop promotes pancreatic ductal adenocarcinoma progression via miRNA sponging and A-to-I RNA-editing.
Shen P; Yang T; Chen Q; Yuan H; Wu P; Cai B; Meng L; Huang X; Liu J; Zhang Y; Hu W; Miao Y; Lu Z; Jiang K
Mol Cancer; 2021 Mar; 20(1):51. PubMed ID: 33750389
[TBL] [Abstract][Full Text] [Related]
22. circNFIB1 inhibits lymphangiogenesis and lymphatic metastasis via the miR-486-5p/PIK3R1/VEGF-C axis in pancreatic cancer.
Kong Y; Li Y; Luo Y; Zhu J; Zheng H; Gao B; Guo X; Li Z; Chen R; Chen C
Mol Cancer; 2020 May; 19(1):82. PubMed ID: 32366257
[TBL] [Abstract][Full Text] [Related]
23. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells.
Li L; Li Z; Kong X; Xie D; Jia Z; Jiang W; Cui J; Du Y; Wei D; Huang S; Xie K
Gastroenterology; 2014 Aug; 147(2):485-97.e18. PubMed ID: 24859161
[TBL] [Abstract][Full Text] [Related]
25. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.
Chaudhary AK; Mondal G; Kumar V; Kattel K; Mahato RI
Cancer Lett; 2017 Aug; 402():1-8. PubMed ID: 28536008
[TBL] [Abstract][Full Text] [Related]
26. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
[TBL] [Abstract][Full Text] [Related]
27. The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells.
Cioffi M; Trabulo SM; Sanchez-Ripoll Y; Miranda-Lorenzo I; Lonardo E; Dorado J; Reis Vieira C; Ramirez JC; Hidalgo M; Aicher A; Hahn S; Sainz B; Heeschen C
Gut; 2015 Dec; 64(12):1936-48. PubMed ID: 25887381
[TBL] [Abstract][Full Text] [Related]
28. Deguelin suppresses pancreatic tumor growth and metastasis by inhibiting epithelial-to-mesenchymal transition in an orthotopic model.
Boreddy SR; Srivastava SK
Oncogene; 2013 Aug; 32(34):3980-91. PubMed ID: 22986522
[TBL] [Abstract][Full Text] [Related]
29. Prolactin receptor potentiates chemotherapy through miRNAs-induced G6PD/TKT inhibition in pancreatic cancer.
Liao YN; Huang PQ; Pan H; Gai YZ; Zhan YF; Li SX; Nie HZ
FASEB J; 2024 May; 38(10):e23705. PubMed ID: 38805171
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-148a suppresses epithelial-mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/β-catenin signaling pathway.
Peng L; Liu Z; Xiao J; Tu Y; Wan Z; Xiong H; Li Y; Xiao W
Oncol Rep; 2017 Jul; 38(1):301-308. PubMed ID: 28586066
[TBL] [Abstract][Full Text] [Related]
31. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
[TBL] [Abstract][Full Text] [Related]
32. A Histone Methylation-MAPK Signaling Axis Drives Durable Epithelial-Mesenchymal Transition in Hypoxic Pancreatic Cancer.
Brown BA; Myers PJ; Adair SJ; Pitarresi JR; Sah-Teli SK; Campbell LA; Hart WS; Barbeau MC; Leong K; Seyler N; Kane W; Lee KE; Stelow E; Jones M; Simon MC; Koivunen P; Bauer TW; Stanger BZ; Lazzara MJ
Cancer Res; 2024 Jun; 84(11):1764-1780. PubMed ID: 38471099
[TBL] [Abstract][Full Text] [Related]
33. microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions.
Ouyang H; Gore J; Deitz S; Korc M
Oncogene; 2014 Sep; 33(38):4664-74. PubMed ID: 24096486
[TBL] [Abstract][Full Text] [Related]
34. Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1 axis.
Xian G; Zhao J; Qin C; Zhang Z; Lin Y; Su Z
Cancer Lett; 2017 Jan; 385():65-74. PubMed ID: 27840243
[TBL] [Abstract][Full Text] [Related]
35. Molecular pathogenesis of pancreatic ductal adenocarcinoma: Impact of passenger strand of pre-miR-148a on gene regulation.
Idichi T; Seki N; Kurahara H; Fukuhisa H; Toda H; Shimonosono M; Okato A; Arai T; Kita Y; Mataki Y; Kijima Y; Maemura K; Natsugoe S
Cancer Sci; 2018 Jun; 109(6):2013-2026. PubMed ID: 29660218
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-448 suppresses metastasis of pancreatic ductal adenocarcinoma through targeting JAK1/STAT3 pathway.
Yu DL; Zhang T; Wu K; Li Y; Wang J; Chen J; Li XQ; Peng XG; Wang JN; Tan LG
Oncol Rep; 2017 Aug; 38(2):1075-1082. PubMed ID: 28677798
[TBL] [Abstract][Full Text] [Related]
37. miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma.
Gao W; Gu Y; Li Z; Cai H; Peng Q; Tu M; Kondo Y; Shinjo K; Zhu Y; Zhang J; Sekido Y; Han B; Qian Z; Miao Y
Oncogene; 2015 Mar; 34(13):1629-40. PubMed ID: 24769899
[TBL] [Abstract][Full Text] [Related]
38. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
[TBL] [Abstract][Full Text] [Related]
39. Upregulated circular RNA circ_0007534 indicates an unfavorable prognosis in pancreatic ductal adenocarcinoma and regulates cell proliferation, apoptosis, and invasion by sponging miR-625 and miR-892b.
Hao L; Rong W; Bai L; Cui H; Zhang S; Li Y; Chen D; Meng X
J Cell Biochem; 2019 Mar; 120(3):3780-3789. PubMed ID: 30382592
[TBL] [Abstract][Full Text] [Related]
40. Exosomes secreted from human umbilical cord mesenchymal stem cells promote pancreatic ductal adenocarcinoma growth by transferring miR-100-5p.
Ding Y; Mei W; Zheng Z; Cao F; Liang K; Jia Y; Wang Y; Liu D; Li J; Li F
Tissue Cell; 2021 Dec; 73():101623. PubMed ID: 34543801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
